Ulcerative Colitis Market: Quantifying Market Opportunities Through Market Sizing And Market Forecasting Estimated By Global Key Players Abbvie Inc., Celltrion Healthcare, Johnson And Johnson, F. Hoffmann-La Roche Ag, Warner Chilcott, Janssen Pharmaceutic

Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained weight loss, loss of appetite, joint pain, eye disease, thickening of the intestinal wall, blood infection (sepsis), kidney stones and liver disease. The diagnosis of this disease can be carried out by physical examination using tests such as colonoscopy, endoscopy, biopsy, CT scan and blood test.

Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/238

If ulcerative colitis persists for over 8 years or longer, it may lead to colon cancer. The people having mild symptoms of this disease can be cured by over the counter drugs such as Imodium therapy. However, transcription medicine such as steroid medicines and amino salicylates are widely used to treat the condition. In severe cases, the patient may need to undergo surgery to remove the colon, which also helps prevent colon cancer.

Global Key Players:

Some major companies playing leading role in ulcerative colitis market are
AbbVie Inc.
Hospira
Celltrion Healthcare
Johnson and Johnson
F. Hoffmann-La Roche AG
Warner Chilcott
Janssen Pharmaceuticals Inc.
Takeda Pharmaceuticals Company Ltd.

Ulcerative Colitis Market Taxonomy:

Global Market by Drug Type

Infliximab
Golimumab
Adalimumab
Vedolizumab
Mesalamine
Budesonide
Balsazide

Global Market by Dosage Form

Parenteral
Oral

Global Market by Geography

North America
Europe
APAC
Latin America
Middle East
Africa

Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/238

High Prevalence In Developed Regions And Increasing Incidence Rate In Emerging Economies Will Play Major Role In Driving Growth Of The Ulcerative Colitis Market:

According to the study of CCFA, industrialized countries have highest incidence rate for ulcerative colitis. This disease is most prevalent in urban areas than in rural areas, also it can affect to any age group of people but most cases diagnosed are of the age in between 15 to 35. According the stats of World Gastroenterology Organization (WGO), there is rising incidence rate in emerging economies such as India. Due to changing diet and lifestyle pattern, the emerging economies will show high growth rate in incidence rate of ulcerative colitis in the near future.

According to data collected from various sources and compiled by Coherent Market Insights, Europe have the highest annual rate of incidence worldwide, followed by North America and the lowest in Asia and Middle East.

However, North America holds the largest share in the global ulcerative colitis market due to continuous improvements in drugs, increased uptake of medicines, awareness about treatment and increasing clinical research. APAC region will show high growth in ulcerative colitis market during forecast years (2017-2024), due to raising awareness about the treatment, changing lifestyle will cause to increase prevalence and incidence rate, entry of new drugs in the market also some companies losing their patent of ulcerative drugs in coming years, like Humira (adalimumab) lost its patent in 2016 and Remicade will lose its patent in 2018. Also, some drugs companies have launched their biosimilar drugs in ulcerative colitis industry. For example, in 2016, India-based Torrent Pharmaceuticals launched a biosimilar drug under the brand name Adfra to compete Humira. Humira is a trade name for adalimumab medication owned by AbbVie Inc.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/ulcerative-colitis-market-238

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.